Cargando…

Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)

BACKGROUND: Etoposide (E) at 100 mg/m(2) combined with Cisplatin (P) at 20 mg/m(2) represents an induction 2-day regimen embedded in our clinical practice for patients with advanced GCT or TN at high risk of early death. We evaluated 24/7 Em-EP administration to a combined GCT-TN cohort at our Emerg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan Wah Hak, Charleen, Coyle, Christopher, Kocache, Arwa, Short, Dee, Sarwar, Naveed, Seckl, Michael J., Gonzalez, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683367/ https://www.ncbi.nlm.nih.gov/pubmed/31382912 http://dx.doi.org/10.1186/s12885-019-5968-7

Ejemplares similares

Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)

Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia
por: Wang, Ming, et al.
Publicado: (2021)

A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
por: Powles, T, et al.
Publicado: (2007)

Residual lung lesions after completion of chemotherapy for gestational trophoblastic neoplasia: should we operate?
por: Powles, T, et al.
Publicado: (2006)

Challenges in the diagnosis and treatment of gestational trophoblastic neoplasia worldwide
por: Braga, Antonio, et al.
Publicado: (2019)

PREDICT‐GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia?
por: Parker, Victoria L., et al.
Publicado: (2022)

Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors
por: Openshaw, Mark R., et al.
Publicado: (2015)

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia
por: Agarwal, R, et al.
Publicado: (2012)

Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours
por: Froeling, Fieke E. M., et al.
Publicado: (2019)

The management and outcome of women with post-hydatidiform mole ‘low-risk’ gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l(−1)
por: McGrath, S, et al.
Publicado: (2010)

Serum human chorionic gonadotropin ratios for the detection of etoposide, methotrexate, dactinomycin, cyclophosphamide, and vincristine resistance in high‐risk gestational trophoblastic neoplasia
por: Sirimusika, Nathapol, et al.
Publicado: (2022)

Gestational trophoblastic neoplasia in the 1990s.
por: Goldstein, D. P.
Publicado: (1991)

Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy
por: Cortés-Charry, R., et al.
Publicado: (2021)

Spontaneous regression of gestational trophoblastic neoplasia
por: Niimi, Kaoru, et al.
Publicado: (2017)

Dysgerminoma Masquerading as Gestational Trophoblastic Neoplasia
por: Blackwell, Conner, et al.
Publicado: (2023)

High-dose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia
por: El-Helw, L M, et al.
Publicado: (2005)

Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide
por: Kanno, Toshiyuki, et al.
Publicado: (2018)

Dedifferentiated endometrioid adenocarcinoma with trophoblastic components: Prolonged remission after treatment with bleomycin, etoposide, and cisplatin
por: Martin, Alexa K., et al.
Publicado: (2020)

A review on management of gestational trophoblastic neoplasia
por: Sharami, Seyedeh Reyhaneh Yousefi, et al.
Publicado: (2020)

Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic Neoplasia
por: Ramírez, Luz Angela Correa, et al.
Publicado: (2022)

Current Chemotherapeutic Management of Patients with Gestational Trophoblastic Neoplasia
por: May, Taymaa, et al.
Publicado: (2011)

Role of surgical therapy in the management of gestational trophoblastic neoplasia
por: Eoh, Kyung Jin, et al.
Publicado: (2015)

Gestational trophoblastic neoplasia: experience at Salah Azaiez Institute
por: Batti, Rim, et al.
Publicado: (2019)

Conservative management of uterine rupture in gestational trophoblastic neoplasia
por: David-West, Gizelka, et al.
Publicado: (2020)

Predictors of chemotherapy resistance & relapse in gestational trophoblastic neoplasia
por: Singhal, Seema, et al.
Publicado: (2020)

Gestational trophoblastic neoplasia presenting as an interstitial ectopic pregnancy
por: Toal, C., et al.
Publicado: (2021)

Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN)
por: Mangili, Giorgia, et al.
Publicado: (2022)

Methotrexate pneumonitis in a patient with gestational trophoblastic neoplasia
por: Agarwal, M, et al.
Publicado: (2022)

Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia
por: Braga, Antonio, et al.
Publicado: (2021)

Early prediction of treatment resistance in low-risk gestational trophoblastic neoplasia using population kinetic modelling of hCG measurements
por: You, B, et al.
Publicado: (2013)

GCT-48. OUTCOME OF CNS MALIGNANT NON-GERMINOMATOUS GERM CELL TUMORS (GCT) WITH AFP > 1000 ng/ml AT DIAGNOSIS TREATED ACCORDING TO SIOP CNS GCT 96
por: Calaminus, Gabriele, et al.
Publicado: (2020)

Gestational trophoblastic neoplasia of intermediate trophoblasts: Epithelioid trophoblastic tumor and placental site trophoblastic tumor, a study of morphologic, immunohistochemical, and next generation sequencing
por: Öz Atalay, Fatma, et al.
Publicado: (2023)

The GCT Matrix Card and its Applications
por: Jones, J, et al.
Publicado: (2009)

Arthroscope assisted intralesional curettage of GCT
por: Kekatpure, Aashay, et al.
Publicado: (2015)

Giant Cell Tumor (GCT) of Capitate
por: Narayana Gowda, BS, et al.
Publicado: (2012)

GCT-61. CORRELATION OF PATTERNS OF DISEASE RECURRENCE WITH RADIOTHERAPY TECHNIQUES AND DOSE IN INTRACRANIAL GERM CELL TUMOURS (icGCT): LESSONS FROM THE UK COHORT OF SIOP GCT96 STUDY
por: Ajithkumar, Thankamma, et al.
Publicado: (2020)

Fatal Cases of Gestational Trophoblastic Neoplasia in a National Trophoblastic Disease Reference Center in Dakar Senegal
por: Gueye, Mamour, et al.
Publicado: (2016)

Gestational trophoblastic neoplasia with retroperitoneal metastases: A fatal complication
por: Thomakos, Nikolaos, et al.
Publicado: (2010)

Gestational trophoblastic neoplasia: A 6 year retrospective study
por: Shrivastava, Sushruta, et al.
Publicado: (2014)

Human chorionic gonadotrophin as an indicator of persistent gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m4qmudv7jmqm02225b2t4jk7mh